DEXELANCE SPA (DEX.MI) Fundamental Analysis & Valuation

BIT:DEX • IT0005543480

Current stock price

2.805 EUR
+0.01 (+0.18%)
Last:

This DEX.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. DEX.MI Profitability Analysis

1.1 Basic Checks

  • In the past year DEX was profitable.
  • In the past year DEX had a positive cash flow from operations.
  • Of the past 5 years DEX 4 years were profitable.
  • In the past 5 years DEX always reported a positive cash flow from operatings.
DEX.MI Yearly Net Income VS EBIT VS OCF VS FCFDEX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

  • DEX has a Return On Assets (2.20%) which is in line with its industry peers.
  • The Return On Equity of DEX (5.87%) is better than 60.61% of its industry peers.
  • With a Return On Invested Capital value of 3.48%, DEX perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DEX is in line with the industry average of 9.69%.
  • The last Return On Invested Capital (3.48%) for DEX is well below the 3 year average (7.89%), which needs to be investigated, but indicates that DEX had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.2%
ROE 5.87%
ROIC 3.48%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
DEX.MI Yearly ROA, ROE, ROICDEX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

  • DEX has a Profit Margin (1.97%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of DEX has declined.
  • Looking at the Operating Margin, with a value of 2.98%, DEX is in line with its industry, outperforming 45.45% of the companies in the same industry.
  • DEX's Operating Margin has declined in the last couple of years.
  • The Gross Margin of DEX (37.82%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of DEX has grown nicely.
Industry RankSector Rank
OM 2.98%
PM (TTM) 1.97%
GM 37.82%
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
DEX.MI Yearly Profit, Operating, Gross MarginsDEX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DEX.MI Health Analysis

2.1 Basic Checks

  • DEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • DEX has less shares outstanding than it did 1 year ago.
  • DEX has a better debt/assets ratio than last year.
DEX.MI Yearly Shares OutstandingDEX.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
DEX.MI Yearly Total Debt VS Total AssetsDEX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • DEX has an Altman-Z score of 1.64. This is a bad value and indicates that DEX is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.64, DEX is doing worse than 63.64% of the companies in the same industry.
  • DEX has a debt to FCF ratio of 23.75. This is a negative value and a sign of low solvency as DEX would need 23.75 years to pay back of all of its debts.
  • DEX's Debt to FCF ratio of 23.75 is in line compared to the rest of the industry. DEX outperforms 48.48% of its industry peers.
  • A Debt/Equity ratio of 0.34 indicates that DEX is not too dependend on debt financing.
  • The Debt to Equity ratio of DEX (0.34) is better than 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 23.75
Altman-Z 1.64
ROIC/WACC0.6
WACC5.78%
DEX.MI Yearly LT Debt VS Equity VS FCFDEX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

  • DEX has a Current Ratio of 1.06. This is a normal value and indicates that DEX is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of DEX (1.06) is worse than 72.73% of its industry peers.
  • DEX has a Quick Ratio of 1.06. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of DEX (0.75) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.75
DEX.MI Yearly Current Assets VS Current LiabilitesDEX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DEX.MI Growth Analysis

3.1 Past

  • DEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -65.75%.
  • The Earnings Per Share has been growing by 16.38% on average over the past years. This is quite good.
  • The Revenue has grown by 9.70% in the past year. This is quite good.
  • DEX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.04% yearly.
EPS 1Y (TTM)-65.75%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-825%
Revenue 1Y (TTM)9.7%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%2.53%

3.2 Future

  • The Earnings Per Share is expected to decrease by -8.46% on average over the next years.
  • DEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.23% yearly.
EPS Next Y-43.72%
EPS Next 2Y-15.18%
EPS Next 3Y-8.46%
EPS Next 5YN/A
Revenue Next Year4.31%
Revenue Next 2Y5.75%
Revenue Next 3Y5.23%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DEX.MI Yearly Revenue VS EstimatesDEX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
DEX.MI Yearly EPS VS EstimatesDEX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

6

4. DEX.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.50 indicates a reasonable valuation of DEX.
  • Compared to the rest of the industry, the Price/Earnings ratio of DEX indicates a rather cheap valuation: DEX is cheaper than 81.82% of the companies listed in the same industry.
  • DEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.23.
  • Based on the Price/Forward Earnings ratio of 4.56, the valuation of DEX can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, DEX is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
  • DEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.5
Fwd PE 4.56
DEX.MI Price Earnings VS Forward Price EarningsDEX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DEX is valued cheaper than 93.94% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DEX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 21.18
EV/EBITDA 3.42
DEX.MI Per share dataDEX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A cheap valuation may be justified as DEX's earnings are expected to decrease with -8.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.18%
EPS Next 3Y-8.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DEX.MI Dividend Analysis

5.1 Amount

  • No dividends for DEX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DEX.MI Fundamentals: All Metrics, Ratios and Statistics

DEXELANCE SPA

BIT:DEX (3/20/2026, 5:27:38 PM)

2.805

+0.01 (+0.18%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners13.6%
Inst Owner ChangeN/A
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap75.54M
Revenue(TTM)481.13M
Net Income(TTM)9.48M
Analysts85.71
Price Target8.91 (217.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 8.5
Fwd PE 4.56
P/S 0.16
P/FCF 21.18
P/OCF 7.18
P/B 0.47
P/tB N/A
EV/EBITDA 3.42
EPS(TTM)0.33
EY11.76%
EPS(NY)0.62
Fwd EY21.94%
FCF(TTM)0.13
FCFY4.72%
OCF(TTM)0.39
OCFY13.92%
SpS17.87
BVpS6
TBVpS-2.2
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.67
Profitability
Industry RankSector Rank
ROA 2.2%
ROE 5.87%
ROCE 4.78%
ROIC 3.48%
ROICexc 3.89%
ROICexgc 22.15%
OM 2.98%
PM (TTM) 1.97%
GM 37.82%
FCFM 0.74%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
ROICexc(3y)10.38%
ROICexc(5y)9.17%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.86%
ROCE(5y)9.5%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-10.93%
ROICexc growth 5YN/A
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
F-Score7
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 23.75
Debt/EBITDA 1.49
Cap/Depr 30.32%
Cap/Sales 1.44%
Interest Coverage 250
Cash Conversion 28.23%
Profit Quality 37.61%
Current Ratio 1.06
Quick Ratio 0.75
Altman-Z 1.64
F-Score7
WACC5.78%
ROIC/WACC0.6
Cap/Depr(3y)32.47%
Cap/Depr(5y)34.25%
Cap/Sales(3y)1.91%
Cap/Sales(5y)2.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.75%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-825%
EPS Next Y-43.72%
EPS Next 2Y-15.18%
EPS Next 3Y-8.46%
EPS Next 5YN/A
Revenue 1Y (TTM)9.7%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%2.53%
Revenue Next Year4.31%
Revenue Next 2Y5.75%
Revenue Next 3Y5.23%
Revenue Next 5YN/A
EBIT growth 1Y-62.21%
EBIT growth 3Y25.09%
EBIT growth 5YN/A
EBIT Next Year1.44%
EBIT Next 3Y9.74%
EBIT Next 5YN/A
FCF growth 1Y-74.95%
FCF growth 3Y8.28%
FCF growth 5YN/A
OCF growth 1Y-42.38%
OCF growth 3Y11.3%
OCF growth 5YN/A

DEXELANCE SPA / DEX.MI Fundamental Analysis FAQ

What is the fundamental rating for DEX stock?

ChartMill assigns a fundamental rating of 4 / 10 to DEX.MI.


What is the valuation status for DEX stock?

ChartMill assigns a valuation rating of 6 / 10 to DEXELANCE SPA (DEX.MI). This can be considered as Fairly Valued.


What is the profitability of DEX stock?

DEXELANCE SPA (DEX.MI) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for DEX stock?

The Price/Earnings (PE) ratio for DEXELANCE SPA (DEX.MI) is 8.5 and the Price/Book (PB) ratio is 0.47.


What is the financial health of DEXELANCE SPA (DEX.MI) stock?

The financial health rating of DEXELANCE SPA (DEX.MI) is 3 / 10.